These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS. Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276 [Abstract] [Full Text] [Related]
5. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice. Zanesi N, Aqeilan R, Drusco A, Kaou M, Sevignani C, Costinean S, Bortesi L, La Rocca G, Koldovsky P, Volinia S, Mancini R, Calin G, Scott CP, Pekarsky Y, Croce CM. Cancer Res; 2006 Jan 15; 66(2):915-20. PubMed ID: 16424025 [Abstract] [Full Text] [Related]
13. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Bresin A, Callegari E, D'Abundo L, Cattani C, Bassi C, Zagatti B, Narducci MG, Caprini E, Pekarsky Y, Croce CM, Sabbioni S, Russo G, Negrini M. Oncotarget; 2015 Aug 14; 6(23):19807-18. PubMed ID: 26090867 [Abstract] [Full Text] [Related]
14. Animal models for chronic lymphocytic leukemia. Pekarsky Y, Zanesi N, Aqeilan RI, Croce CM. J Cell Biochem; 2007 Apr 01; 100(5):1109-18. PubMed ID: 17131382 [Abstract] [Full Text] [Related]
15. The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafish. Auer RL, Riaz S, Cotter FE. Br J Haematol; 2007 Jun 01; 137(5):443-53. PubMed ID: 17488487 [Abstract] [Full Text] [Related]
16. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia. Dickinson JD, Smith LM, Sanger WG, Zhou G, Townley P, Lynch JC, Pavletic ZS, Bierman PJ, Joshi SS. Br J Haematol; 2005 Feb 01; 128(4):460-71. PubMed ID: 15686453 [Abstract] [Full Text] [Related]
17. Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia. Sivina M, Hartmann E, Vasyutina E, Boucas JM, Breuer A, Keating MJ, Wierda WG, Rosenwald A, Herling M, Burger JA. Leukemia; 2012 Aug 01; 26(8):1812-20. PubMed ID: 22460735 [Abstract] [Full Text] [Related]
18. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Yuille MR, Condie A, Stone EM, Wilsher J, Bradshaw PS, Brooks L, Catovsky D. Genes Chromosomes Cancer; 2001 Apr 01; 30(4):336-41. PubMed ID: 11241786 [Abstract] [Full Text] [Related]
19. The TCL1 mouse as a model for chronic lymphocytic leukemia. Hamblin TJ. Leuk Res; 2010 Feb 01; 34(2):135-6. PubMed ID: 19726084 [Abstract] [Full Text] [Related]
20. All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia. Lichter P. Cancer Cell; 2010 Jan 19; 17(1):3-4. PubMed ID: 20129242 [Abstract] [Full Text] [Related] Page: [Next] [New Search]